Sponsored by:

Nuclear Medicine: Page 332

Neoprobe nets financing
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe of Dublin, OH, has signed a finance agreement, the company reported.
December 26, 2007
ASRT: First-year enrollments flat
By AuntMinnie.com staff writers
A survey from the American Society of Radiologic Technologists (ASRT) shows that entering-class enrollments in radiography, radiation therapy, and nuclear medicine programs in 2007 remained steady.
December 20, 2007
Monrol to build PET centers in Turkey, Romania
By AuntMinnie.com staff writers
Turkish radiopharmaceutical producer Monrol Nuclear Products Industry and Trade of Gebze has announced that it plans to build two new PET radiotracer production centers, one in Turkey and the other in Romania.
December 20, 2007
GE to sell Draxis generic MIBI
By AuntMinnie.com staff writers
Canadian radiopharmaceutical developer Draxis Health of Mississauga, Ontario, has signed a deal with GE Healthcare giving the Chalfont St. Giles, U.K.-based company rights to sell Draxis generic technetium-99m sestamibi in the U.S.
December 20, 2007
Dilon, Naviscan settle patent dispute
By AuntMinnie.com staff writers
Scintimammography developer Dilon Technologies of Newport News, VA, and PET developer Naviscan PET Systems of San Diego have buried the hatchet in a dispute over patent technologies.
December 20, 2007
Neoprobe extends agreement with Ethicon
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe of Dublin, OH, has extended its marketing and distribution agreement with Ethicon Endo-Surgery of Cincinnati.
December 19, 2007
Bristol-Myers Squibb finds buyer for imaging unit
By AuntMinnie.com staff writers
Pharmaceutical developer Bristol-Myers Squibb of New York City has inked a deal to sell its medical imaging unit to a private equity firm for $525 million. The deal will include the division's portfolio of contrast products, including its popular Cardiolite radiopharmaceutical for cardiac SPECT imaging.
December 16, 2007
MDS expects less impact from reactor shutdown
By AuntMinnie.com staff writers
MDS, parent company to radioisotope developer MDS Nordion of Kanata, Ontario, said the temporary shutdown of the Chalk River nuclear reactor will have less of a financial impact on the company than anticipated.
December 16, 2007
Canadian Senate OKs Chalk River restart
By AuntMinnie.com staff writers
The Senate in Canada's Parliament last night approved legislation to restart the Chalk River nuclear reactor, which manufactures radioisotopes for nuclear medicine applications.
December 12, 2007
MU seeks funds for new molybdenum-99 source
By AuntMinnie.com staff writers
The Missouri University Research Reactor (MURR) Center is hoping to become a U.S. supplier of molybdenum-99 (Mo-99), aiming to reduce reliance on foreign sources for the base isotope for technetium-99m.
December 11, 2007
Cellectar opens new facility
By AuntMinnie.com staff writers
Radiopharmaceutical firm Cellectar has opened a new $3.3 million radiopharmaceutical research, development, and manufacturing facility and headquarters in Madison, WI.
December 11, 2007
Cellectar opens new facility
By AuntMinnie.com staff writers
Radiopharmaceutical firm Cellectar has opened a new $3.3 million radiopharmaceutical research, development, and manufacturing facility and headquarters in Madison, WI.
December 10, 2007
Previous Page
Page 332 of 440
Next Page